ArticleThe British journal of surgery2024

Cardiovascular and diabetes outcomes among patients with obesity and type 2 diabetes after metabolic bariatric surgery or glucagon-like peptide 1 receptor agonist treatment.

Erik Stenberg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.